AgingResearch.NewsJoin free

MIRZIP-LET-7B

MIRZIP-LET-7B has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Apr 20, 2023: “HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: National Heart, Lung, and Blood Institute and 4 more
  • Humans1

What did studies of MIRZIP-LET-7B find?

1

Studies of MIRZIP-LET-7B measured 1 outcome; the most studied are atherosclerosis (1 study).

Atherosclerosis

downin mice1

1 study

  1. MIRZIP-LET-7B decreases atherosclerosis in mice.

    “MSC (mesenchymal stromal cell)-derived tailored EVs (TEVs) loaded with the antagomir for let-7b-5p (miRZip-let-7b) counteracted”

    Animalsin vivo in apoE-/- mice

    HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs

    International journal of molecular sciences

More on Atherosclerosis

Latest

Related